The need to test the theories behind the Polypill: rationale behind the Indian Polycap Study

Nat Clin Pract Cardiovasc Med. 2009 Feb;6(2):96-7. doi: 10.1038/ncpcardio1438. Epub 2008 Dec 23.
No abstract available

Publication types

  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Administration, Oral
  • Adrenergic beta-Antagonists / administration & dosage
  • Angiotensin-Converting Enzyme Inhibitors / administration & dosage
  • Aspirin / administration & dosage
  • Atenolol / administration & dosage
  • Capsules
  • Cardiovascular Agents / administration & dosage*
  • Cardiovascular Agents / economics
  • Cardiovascular Diseases / drug therapy*
  • Diuretics / administration & dosage
  • Double-Blind Method
  • Drug Combinations
  • Drug Costs
  • Humans
  • Hydrochlorothiazide / administration & dosage
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage
  • India
  • Platelet Aggregation Inhibitors / administration & dosage
  • Primary Prevention
  • Ramipril / administration & dosage
  • Research Design
  • Secondary Prevention
  • Simvastatin / administration & dosage
  • Treatment Outcome

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Capsules
  • Cardiovascular Agents
  • Diuretics
  • Drug Combinations
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Platelet Aggregation Inhibitors
  • Hydrochlorothiazide
  • Atenolol
  • Simvastatin
  • Ramipril
  • Aspirin

Associated data

  • ClinicalTrials.gov/NCT00443794